Cadus Corporation (OTC:KDUS)

Cadus Corporation, through its subsidiary, Cadus Technologies, Inc., focuses on licensing yeast-based and other drug discovery technologies to third parties. Its technologies are used to identify small molecules that act as agonists or antagonists to cell surface receptors. The company was formerly known as Cadus Pharmaceutical Corporation and changed its name to Cadus Corporation in June 2003. Cadus Corporation was founded in 1992 and is based in New York, New York.

Last updated January 2, 2014